CN117551818B - 一种检测呼吸道合胞病毒的靶基因、引物探针组合以及试剂盒和应用 - Google Patents
一种检测呼吸道合胞病毒的靶基因、引物探针组合以及试剂盒和应用 Download PDFInfo
- Publication number
- CN117551818B CN117551818B CN202410038685.2A CN202410038685A CN117551818B CN 117551818 B CN117551818 B CN 117551818B CN 202410038685 A CN202410038685 A CN 202410038685A CN 117551818 B CN117551818 B CN 117551818B
- Authority
- CN
- China
- Prior art keywords
- respiratory syncytial
- seq
- syncytial virus
- kit
- nucleotide sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000523 sample Substances 0.000 title claims abstract description 52
- 241000725643 Respiratory syncytial virus Species 0.000 title claims abstract description 51
- 108090000623 proteins and genes Proteins 0.000 title abstract description 12
- 238000001514 detection method Methods 0.000 claims abstract description 47
- 239000012634 fragment Substances 0.000 claims abstract description 12
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 23
- 230000003321 amplification Effects 0.000 claims description 22
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 20
- 102100031780 Endonuclease Human genes 0.000 claims description 19
- 241000193755 Bacillus cereus Species 0.000 claims description 18
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 18
- 239000002773 nucleotide Substances 0.000 claims description 17
- 125000003729 nucleotide group Chemical group 0.000 claims description 17
- 102000018120 Recombinases Human genes 0.000 claims description 16
- 108010091086 Recombinases Proteins 0.000 claims description 16
- 230000001404 mediated effect Effects 0.000 claims description 15
- 108010042407 Endonucleases Proteins 0.000 claims description 14
- DRBBFCLWYRJSJZ-UHFFFAOYSA-N N-phosphocreatine Chemical compound OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 claims description 12
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 claims description 12
- 108020004414 DNA Proteins 0.000 claims description 10
- 108020004707 nucleic acids Proteins 0.000 claims description 10
- 102000039446 nucleic acids Human genes 0.000 claims description 10
- 150000007523 nucleic acids Chemical class 0.000 claims description 10
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 9
- 102000052510 DNA-Binding Proteins Human genes 0.000 claims description 8
- 102000034356 gene-regulatory proteins Human genes 0.000 claims description 8
- 108091006104 gene-regulatory proteins Proteins 0.000 claims description 8
- 102000004594 DNA Polymerase I Human genes 0.000 claims description 7
- 108010017826 DNA Polymerase I Proteins 0.000 claims description 7
- 101710116602 DNA-Binding protein G5P Proteins 0.000 claims description 7
- 102000001218 Rec A Recombinases Human genes 0.000 claims description 7
- 108010055016 Rec A Recombinases Proteins 0.000 claims description 7
- 101710162453 Replication factor A Proteins 0.000 claims description 7
- 101710176758 Replication protein A 70 kDa DNA-binding subunit Proteins 0.000 claims description 7
- 101710176276 SSB protein Proteins 0.000 claims description 7
- 101710126859 Single-stranded DNA-binding protein Proteins 0.000 claims description 7
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 6
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 6
- 102000004420 Creatine Kinase Human genes 0.000 claims description 6
- 108010042126 Creatine kinase Proteins 0.000 claims description 6
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 6
- 239000002202 Polyethylene glycol Substances 0.000 claims description 6
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims description 6
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 6
- GFIHKCBJSYGAPP-UHFFFAOYSA-N [Cl-].C(=O)=CC[PH+](CC=C=O)CC=C=O Chemical compound [Cl-].C(=O)=CC[PH+](CC=C=O)CC=C=O GFIHKCBJSYGAPP-UHFFFAOYSA-N 0.000 claims description 6
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 6
- 229960003589 arginine hydrochloride Drugs 0.000 claims description 6
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 claims description 6
- 229940069446 magnesium acetate Drugs 0.000 claims description 6
- 235000011285 magnesium acetate Nutrition 0.000 claims description 6
- 239000011654 magnesium acetate Substances 0.000 claims description 6
- 238000012986 modification Methods 0.000 claims description 6
- 230000004048 modification Effects 0.000 claims description 6
- 229920001223 polyethylene glycol Polymers 0.000 claims description 6
- 235000011056 potassium acetate Nutrition 0.000 claims description 6
- 238000010791 quenching Methods 0.000 claims description 6
- 230000000171 quenching effect Effects 0.000 claims description 6
- 239000000872 buffer Substances 0.000 claims description 5
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 claims description 4
- 239000000427 antigen Substances 0.000 claims description 3
- 102000036639 antigens Human genes 0.000 claims description 3
- 108091007433 antigens Proteins 0.000 claims description 3
- 229960002685 biotin Drugs 0.000 claims description 3
- 235000020958 biotin Nutrition 0.000 claims description 3
- 239000011616 biotin Substances 0.000 claims description 3
- JZODKRWQWUWGCD-UHFFFAOYSA-N 2,5-di-tert-butylbenzene-1,4-diol Chemical compound CC(C)(C)C1=CC(O)=C(C(C)(C)C)C=C1O JZODKRWQWUWGCD-UHFFFAOYSA-N 0.000 claims description 2
- UDGUGZTYGWUUSG-UHFFFAOYSA-N 4-[4-[[2,5-dimethoxy-4-[(4-nitrophenyl)diazenyl]phenyl]diazenyl]-n-methylanilino]butanoic acid Chemical compound COC=1C=C(N=NC=2C=CC(=CC=2)N(C)CCCC(O)=O)C(OC)=CC=1N=NC1=CC=C([N+]([O-])=O)C=C1 UDGUGZTYGWUUSG-UHFFFAOYSA-N 0.000 claims description 2
- WCKQPPQRFNHPRJ-UHFFFAOYSA-N 4-[[4-(dimethylamino)phenyl]diazenyl]benzoic acid Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=CC=C(C(O)=O)C=C1 WCKQPPQRFNHPRJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000003086 colorant Substances 0.000 claims description 2
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 claims description 2
- 230000035945 sensitivity Effects 0.000 abstract description 11
- 238000004458 analytical method Methods 0.000 abstract description 7
- 238000002474 experimental method Methods 0.000 abstract description 6
- 239000003550 marker Substances 0.000 abstract description 3
- 238000000034 method Methods 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 15
- 238000011901 isothermal amplification Methods 0.000 description 12
- 239000007788 liquid Substances 0.000 description 9
- 238000005516 engineering process Methods 0.000 description 8
- 238000002795 fluorescence method Methods 0.000 description 8
- 238000011144 upstream manufacturing Methods 0.000 description 8
- 238000013461 design Methods 0.000 description 7
- 239000011324 bead Substances 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 238000002156 mixing Methods 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 238000001917 fluorescence detection Methods 0.000 description 4
- 230000010355 oscillation Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000012295 chemical reaction liquid Substances 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 238000010206 sensitivity analysis Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 108091036078 conserved sequence Proteins 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- WHRNULOCNSKMGB-UHFFFAOYSA-N tetrahydrofuran thf Chemical compound C1CCOC1.C1CCOC1 WHRNULOCNSKMGB-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241001678559 COVID-19 virus Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 101710096438 DNA-binding protein Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 241000712431 Influenza A virus Species 0.000 description 1
- 206010024971 Lower respiratory tract infections Diseases 0.000 description 1
- 241000127282 Middle East respiratory syndrome-related coronavirus Species 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108091081548 Palindromic sequence Proteins 0.000 description 1
- 241000711504 Paramyxoviridae Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010035742 Pneumonitis Diseases 0.000 description 1
- 241000315672 SARS coronavirus Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001615 biotins Chemical class 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003761 preservation solution Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410038685.2A CN117551818B (zh) | 2024-01-11 | 2024-01-11 | 一种检测呼吸道合胞病毒的靶基因、引物探针组合以及试剂盒和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410038685.2A CN117551818B (zh) | 2024-01-11 | 2024-01-11 | 一种检测呼吸道合胞病毒的靶基因、引物探针组合以及试剂盒和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN117551818A CN117551818A (zh) | 2024-02-13 |
CN117551818B true CN117551818B (zh) | 2024-05-10 |
Family
ID=89817001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410038685.2A Active CN117551818B (zh) | 2024-01-11 | 2024-01-11 | 一种检测呼吸道合胞病毒的靶基因、引物探针组合以及试剂盒和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117551818B (zh) |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101545015A (zh) * | 2009-05-11 | 2009-09-30 | 北京海康基因芯片开发有限公司 | 一种检测传染病病原体的方法及试剂盒 |
CN104419713A (zh) * | 2013-09-04 | 2015-03-18 | 中国科学院上海巴斯德研究所 | 基于环介导的等温扩增的人呼吸道合胞病毒检测试剂盒 |
CN105018466A (zh) * | 2015-07-17 | 2015-11-04 | 浙江泰晶生物科技有限公司 | 一种荧光探针法常温等温核酸扩增法 |
CN108359737A (zh) * | 2018-02-11 | 2018-08-03 | 苏州先达基因科技有限公司 | 支原体污染检测方法及应用 |
CN111187862A (zh) * | 2020-03-11 | 2020-05-22 | 浙江省淡水水产研究所 | 一种基于重组酶的大口黑鲈弹状病毒恒温扩增检测试剂盒 |
CN111690776A (zh) * | 2020-06-30 | 2020-09-22 | 潍坊安普未来生物科技有限公司 | 常温等温快速检测新型冠状病毒SARS-CoV-2的引物、探针、试剂、方法及试剂盒 |
CN112301154A (zh) * | 2020-02-06 | 2021-02-02 | 广州普世君安生物科技有限公司 | 一种快速检测呼吸道合胞病毒的rda方法及试剂盒 |
CN114807435A (zh) * | 2022-03-15 | 2022-07-29 | 广州迪澳医疗科技有限公司 | 一种用于呼吸道合胞病毒检测的试剂盒及其应用 |
CN117210612A (zh) * | 2023-08-22 | 2023-12-12 | 安徽医科大学 | 一种检测呼吸道合胞病毒的探针和引物组合及其应用 |
-
2024
- 2024-01-11 CN CN202410038685.2A patent/CN117551818B/zh active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101545015A (zh) * | 2009-05-11 | 2009-09-30 | 北京海康基因芯片开发有限公司 | 一种检测传染病病原体的方法及试剂盒 |
CN104419713A (zh) * | 2013-09-04 | 2015-03-18 | 中国科学院上海巴斯德研究所 | 基于环介导的等温扩增的人呼吸道合胞病毒检测试剂盒 |
CN105018466A (zh) * | 2015-07-17 | 2015-11-04 | 浙江泰晶生物科技有限公司 | 一种荧光探针法常温等温核酸扩增法 |
CN108359737A (zh) * | 2018-02-11 | 2018-08-03 | 苏州先达基因科技有限公司 | 支原体污染检测方法及应用 |
CN112301154A (zh) * | 2020-02-06 | 2021-02-02 | 广州普世君安生物科技有限公司 | 一种快速检测呼吸道合胞病毒的rda方法及试剂盒 |
CN111187862A (zh) * | 2020-03-11 | 2020-05-22 | 浙江省淡水水产研究所 | 一种基于重组酶的大口黑鲈弹状病毒恒温扩增检测试剂盒 |
CN111690776A (zh) * | 2020-06-30 | 2020-09-22 | 潍坊安普未来生物科技有限公司 | 常温等温快速检测新型冠状病毒SARS-CoV-2的引物、探针、试剂、方法及试剂盒 |
CN114807435A (zh) * | 2022-03-15 | 2022-07-29 | 广州迪澳医疗科技有限公司 | 一种用于呼吸道合胞病毒检测的试剂盒及其应用 |
CN117210612A (zh) * | 2023-08-22 | 2023-12-12 | 安徽医科大学 | 一种检测呼吸道合胞病毒的探针和引物组合及其应用 |
Non-Patent Citations (3)
Title |
---|
ACCESSION NO.MH181973.1,Human respiratory syncytial virus A isolate KEN/KILIFI/WGS/1120_19/12/2012, partial genome.《GenBank》.2018,第1页. * |
呼吸道合胞病毒实时荧光定量PCR检测;张其威等;《第一军医大学学报》;20051231;第25卷(第7期);摘要 * |
陈晨.重组酶介导的扩增技术检测呼吸道合胞病毒方法的建立和初步评价.《中国优秀硕士学位论文全文数据库 医药卫生科技辑》.2019,(第2019 年 第01期期),第一部分和第二部分. * |
Also Published As
Publication number | Publication date |
---|---|
CN117551818A (zh) | 2024-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111004870B (zh) | 新型冠状病毒n基因核酸检测试剂盒 | |
CN114369688B (zh) | 检测SARS-CoV-2奥密克戎变异株的组合物、试剂盒、方法及其用途 | |
CN113881812B (zh) | 检测SARS-CoV-2突变株的组合物、试剂盒、方法及其用途 | |
CN110699489B (zh) | 非洲猪瘟病毒cd2v基因的实时荧光pcr检测引物探针组、试剂盒及方法 | |
CN113046475B (zh) | 一种快速检测突变型新型冠状病毒的引物组合物及试剂盒 | |
CN113930547B (zh) | 猪流行性腹泻病毒n基因的rt-raa荧光法检测引物对、试剂盒及检测方法 | |
CN113652505A (zh) | 检测新型冠状病毒及其voc-202012/01突变株的方法和试剂盒 | |
CN114410848B (zh) | 检测SARS-CoV-2的组合物、试剂盒、方法及其用途 | |
CN111471800B (zh) | 检测新型冠状病毒的试剂盒及其扩增引物组合物 | |
CN112646927B (zh) | 一种用于检测牛结节性皮肤病病毒的荧光型raa试剂盒及其检测方法和应用 | |
KR102267326B1 (ko) | 코로나 바이러스 진단방법 및 진단용 키트 | |
CN112301152B (zh) | 一种快速检测猪伪狂犬病毒、猪圆环病毒、猪细小病毒的多重荧光rda方法及试剂盒 | |
CN116814859A (zh) | 鉴别非洲猪瘟病毒基因ⅰ型和ⅱ型的引物探针组合物、试剂盒及方法 | |
CN117551818B (zh) | 一种检测呼吸道合胞病毒的靶基因、引物探针组合以及试剂盒和应用 | |
CN103215384B (zh) | 鉴别检测绵羊痘病毒和山羊痘病毒的试剂盒 | |
CN106521038B (zh) | 一种高灵敏度的bhv‑2实时荧光定量pcr检测方法及试剂盒 | |
CN112301158B (zh) | 一种快速检测猪瘟病毒(csfv)的rda方法及试剂盒 | |
CN116064954A (zh) | 一种基于mb-rt-pcr检测新型冠状病毒及分型的试剂盒及其应用 | |
CN114395643A (zh) | 非洲猪瘟病毒的双通道数字pcr检测试剂盒及方法 | |
KR102076343B1 (ko) | 실시간 lamp법을 이용한 아데노바이러스 55형 검출용 조성물 및 이의 용도 | |
CN112899385A (zh) | 鉴别布鲁氏菌s2疫苗株与野毒株的引物组、探针及其应用 | |
CN117551817A (zh) | 一种检测甲型流感病毒的靶基因、引物探针组合以及试剂盒和应用 | |
CN112301153A (zh) | 一种快速检测犬冠状病毒(ccv)的rda方法及试剂盒 | |
CN117737310B (zh) | 非洲马瘟和西尼罗病毒的双重实时荧光mira检测引物探针组、试剂盒及方法 | |
CN116042918B (zh) | 五种病毒联检组合物、试剂盒、方法及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240516 Address after: 300457 unit 2, room n212, experimental building, Tianjin International Biomedical Joint Research Institute, No. 220, Dongting Road, economic and Technological Development Zone, Binhai New Area, Tianjin Patentee after: TIANJIN OUDELAI BIOLOGICAL MEDICINE TECHNOLOGY CO.,LTD. Country or region after: China Patentee after: TIANJIN SECOND PEOPLE'S HOSPITAL (TIANJIN INFECTIOUS DISEASE Hospital) Address before: 300457 unit 2, room n212, experimental building, Tianjin International Biomedical Joint Research Institute, No. 220, Dongting Road, economic and Technological Development Zone, Binhai New Area, Tianjin Patentee before: TIANJIN OUDELAI BIOLOGICAL MEDICINE TECHNOLOGY CO.,LTD. Country or region before: China |